Best of Lung Cancer Science - European Society for Medical Oncology (ESMO)
Jessica Donington, MD, and Christine Bestvina, MD, join Dr. Gillaspie to unpack key lung cancer advances from ESMO, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Thinking Thoracic
#21, S2 Breaking the Stigma: Closing Gaps in Lung Cancer Care for Women
#20, S2 Advancing ERAS and the Evolution of Minimally Invasive Thoracic Surgery
#19, S2 Breathing New Life into Emphysema Care
#18, S2 New Advances in Thoracic Surgery at STS 2026
Get summaries like this every morning.
Free AI-powered recaps of Thinking Thoracic and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.